Intravenous immunoglobulins for the treatment of primary Sjögren's syndrome associated painful sensory neuropathies Intravenous immunoglobulins for the treatment of primary Sjögren's syndrome associated painful senso ...
Prospective, randomised, placebo-controlled study of polyvalent intravenous immunoglobulins for the treatment of primary Sjögren's syndrome associated painful sensory neuropathies - TINISS Prospective, randomised, placebo-controlled study of polyvalent intravenous immunoglobulins for the ...
Trade Name: Privigen 100 mg/ml, solution pour perfusion
Hôpitaux Universitaires de Strasbourg
NULL
Authorised-recruitment may be ongoing or finished
Female: yes Male: yes
24
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): yes Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...